TITLE

TREATMENT WITH THE SELECTIVE COX-2 INHIBITOR ROFECOXIB IS ASSOCIATED WITH INCREASED ENDOTHELIAL CELL APOPTOSIS AND DECREASED VASCULARITY OF HUMAN COLORECTAL CANCER LIVER METASTASES

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Treatment with the selective cyclooxygenase-2 inhibitor rofecoxib is associated with a 29 percent decrease in mean microvessel density in colorectal cancer (CRC) liver metastases compared with tumours from patients treated with placebo only. These data suggest that rofecoxib may have anti-angiogenic activity against CRC. This article cites a study to test the hypothesis that rofecoxib treatment is associated with increased endothelial cells (EC) apoptosis in human CRC liver metastases. Results of the study suggest that rofecoxib may induce apoptosis of EC leading to vessel regression and possible antiangiogenic activity in viva.
ACCESSION #
13219278

 

Related Articles

  • Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Tomozawa, S; Tsuno, N H; Sunami, E; Hatano, K; Kitayama, J; Osada, T; Saito, S; Tsuruo, T; Shibata, Y; Nagawa, H // British Journal of Cancer;8/1/2000, Vol. 83 Issue 3, p324 

    Epidemiological studies have demonstrated that nonsteroidal anti-inflammatory drugs (NSAIDs), known to inhibit cyclooxygenase (COX), reduce the risk of colorectal cancer. COX is a key enzyme in prostaglandin biosynthesis, and two isoforms of COX, COX-1 and COX-2, have been identified. Recently...

  • Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells Yamazaki, Ryuta; Kusunoki, Natsuko; Matsuzaki, Takeshi; Hashimoto, Shusuke; Kawai, Shinichi // FEBS Letters;Nov2002, Vol. 531 Issue 2, p278 

    Although the influence of selective cyclooxygenase (COX)-2 inhibitors on the proliferation of colon adenocarcinoma cells have been the subject of much investigation, relatively little research has compared the effects of different COX-2 inhibitors. Celecoxib strongly suppressed the proliferation...

  • Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Onodera, Hisashi; Mori, Akira; Nagayama, Satoshi; Fujimoto, Akihisa; Tachibana, Tsuyoshi; Yonenaga, Yoshikuni; Tsuruyama, Tatsuaki // International Journal of Colorectal Disease;Nov2005, Vol. 20 Issue 6, p477 

    Background: The selection of resective therapy for colorectal hepatic metastases remains controversial. The aim of this study is to investigate the prognostic factors for patients with resected liver metastases from colorectal cancer by analyzing not only clinicopathological factors but also...

  • Prevention of colorectal cancer through the use of COX-2 selective inhibitors. Peek, Richard // Cancer Chemotherapy & Pharmacology. Supplement;Sep2004, Vol. 54, pS50 

    Colorectal cancer is a major cause of morbidity and mortality accounting for an estimated 550,000 deaths annually worldwide. Colonic neoplasia develops in a stepwise fashion progressing from normal mucosa to adenomatous polyps to carcinoma, a process that takes years, thereby providing a prime...

  • Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Agarwal, B.; Swaroop, P.; Protiva, P.; Raj, S. V.; Shirin, H.; Holt, P. R. // Apoptosis;Dec2003, Vol. 8 Issue 6, p649 

    The role of Cox-2 in NSAID-induced apoptosis is debated. We studied the role of Cox-2 inhibition in apoptosis induced by a selective Cox-2 inhibitor, SC236 (a structural analogue of celecoxib) in two colon cancer cell lines, HT29 (expressing Cox-2 protein) and HCT116 (not expressing Cox-2...

  • BOWEL CANCER PREVENTION: ASPIRIN INDUCES COX-2 INDEPENDENT ENDOTHELIAL CELL APOPTOSIS FACILITATING ANGIOGENESIS ARREST. Johnson, A. S.; Arthur, H. M.; Burn, J.; Wilson, R. G. // Gut;Apr2004 Supplement 3, Vol. 53, pA21 

    A study has found that aspirin induces COX-2 independent endothelial cell apoptosis facilitating angiogenesis arrest, an important discovery for bowel cancer prevention. It was found that both aspirin and celecoxib caused dose dependent reduction in cell viability, proliferation and...

  • Cyclo-oxygenase 2 inhibitors: emerging roles in the gut. Grover, J. K.; Yadav, S.; Vats, V.; Joshi, Y. K. // International Journal of Colorectal Disease;Jul2003, Vol. 18 Issue 4, p279 

    Background and aims. Discovery of an isoform of Cyclo-oxygenase (COX) 1, the inducible COX-2, has made it possible to avoid some side effects of non-specific COX inhibitors. The COX-2 gene is over-expressed in reflux oesophagitis, Barrett's oesophagus, gastric and colon cancer, familial...

  • 2. Secondary liver tumours.  // GP: General Practitioner;4/7/2003, p71 

    About 40-50 per cent of patients with colorectal cancer develop secondary tumours in the liver, and many of these can benefit from surgery.Some patients with metastases from gastric cancer, breast cancer, melanoma and carcinoids are also suitable for surgery. Patients with metastatic colorectal...

  • Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. Wagenaar-Miller, R A; Hanley, G; Shattuck-Brandt, R; DuBois, R N; Bell, R L; Matrisian, L M; Morgan, D W // British Journal of Cancer;5/6/2003, Vol. 88 Issue 9, p1445 

    Matrix metalloproteinases (MMPs) and cyclooxygenase-2 (COX-2) are expressed in both sporadic and familial adenomatous colonic polyps and tumours and have been independently shown to play causal roles in intestinal tumour formation in mouse models of colon cancer. The apparent roles of these...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics